DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
<h4>Background</h4>Aberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases of tumor development is largely unknown. Delineating when abnormal DNA methylation arises may provide insight into the natural history of lung adenocarcinoma and the role that DNA m...
Main Authors: | Suhaida A Selamat, Janice S Galler, Amit D Joshi, M Nicky Fyfe, Mihaela Campan, Kimberly D Siegmund, Keith M Kerr, Ite A Laird-Offringa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21731750/?tool=EBI |
Similar Items
-
Coexistence of atypical adenomatous hyperplasia, minimally invasive adenocarcinoma and invasive adenocarcinoma: Gene mutation analysis
by: Junya Song, et al.
Published: (2021-03-01) -
The Value of CT Attenuation in Distinguishing Atypical Adenomatous Hyperplasia from Adenocarcinoma in Situ
by: Binghu JIANG, et al.
Published: (2013-11-01) -
Differences in the structural features of atypical adenomatous hyperplasia and low-grade prostatic adenocarcinoma
by: Ahmet Midi, et al.
Published: (2008-01-01) -
The Role of DNA Methylation in the Development and Progression of Lung Adenocarcinoma
by: Keith M. Kerr, et al.
Published: (2007-01-01) -
Adenosis (Atypical Adenomatous Hyperplasia) of Prostate
by: Dilek Ertoy Baydar
Published: (2015-03-01)